Use of a stochastic model to develop understanding of the impact of different patterns of antiretroviral drug use on resistance development
Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity
Vaginal transmission of HIV-1 in hu-SCID mice: a new model for the evaluation of vaginal microbicides
Osteoblasts in HIV-infected patients: HIV-1 infection and cell function
T cell receptor excision circles and HIV-1 2-LTR episomal DNA to predict AIDS in patients not receiving effective therapy
HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy
CCR5Δ32 and promoter polymorphisms are not correlated with initial virological or immunological treatment response
Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status
The impact of immigration on env HIV-1 subtype distribution among heterosexuals in the Netherlands: influx of subtype B and non-B strains
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance
Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains
HIV-2 does not protect against HIV-1 infection in a rural community in Guinea-Bissau
Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users
Transmission of zidovudine resistant strains of HIV-1: the first wave
Possible protective effect of HIV-2 against incident HIV-1 infection: review of available epidemiological and in vitro data
AIDS — past and future challenges
Drug-resistant mutants of HIV-1 in patients exhibiting increasing CD4 cell count despite virological failure of highly active antiretroviral therapy
Incidence of pregnancies among African HIV-infected women, Abidjan, 1995–2000
Increasing HIV-1 prevalence among pregnant women living in rural areas of the Gulu district (North Uganda)
Protease inhibitors and erectile dysfunction
Pharmacokinetics of amprenavir and lopinavir in combination with nevirapine in highly pretreated HIV-infected patients
Are healthcare providers talking to HIV-seropositive patients about safer sex?
HIV protease inhibitors reduce IL-2 release from normal human phytohaemagglutinin-activated T cells
Wasting and obesity in HIV outpatients
The urgent need for feasibility studies of antiretroviral treatment in HIV-infected individuals in resource-limited settings
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease
Another reality check: the direct costs of providing post-exposure prophylaxis in a population-based programme